Five reasons a Bluefin sale could see Axa avoid another denial headache

Hillary Clinton and Donald Trump

The recent speculation that Marsh was in talks with Axa over a deal to buy its broking arm Bluefin has raised the very real possibility that one of the longest running insurance sagas of recent years could be over.

Having issued more denials than a US presidential hopeful over the future/strategy of broker Bluefin, I am sure Axa will not shed too many tears if the discussions end in an amicable divorce for a host of reasons including these:

1) Sale/no sale 

The UK distribution acquisition strategy that really began with Thinc Destini [October 2006] belonged to a different time and management team, so it has been no surprise that rumours over Bluefin's future have a been a fixture of market gossip

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Broking profits fall at Saga

Underlying profit before tax in Saga’s insurance broking arm fell to £39.8m for the year ended 31 January 2024, compared with £71.5m in the previous period.

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: